Drugs & medicalClass II

Lupin Pharmaceuticals Inc. recalls prednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only, Sterile, a) 5 mL (NDC 70748-332-02); b) 10 mL (NDC 70748-332-03), c) 15…

Presence of Foreign Substance

Read the official notice →
Date
2026-07-08
Country
United States
Brand
Lupin Pharmaceuticals
Product
prednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only, Sterile, a) 5 mL (NDC 70748-332-02); b) 10 mL (NDC 70748-332-03), c) 15 mL…
Classification
Class II
Units
U.S. Nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Lupin Pharmaceuticals recalls

  1. 2026-09-02
  2. US
  3. 2026-07-08
  4. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only,…

    CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.

    FDA · DrugLupin Pharmaceuticals Inc.Nationwide within the U.S.Official notice →
  5. 2026-05-27
  6. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured…

    Presence of particulate matter: a white thread-like structure in the cartridge

    FDA · DrugLupin Pharmaceuticals Inc.Nationwide within U.SOfficial notice →
  7. 2025-12-17
  8. US
  9. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for:…

    Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

    FDA · DrugLupin Pharmaceuticals Inc.FL, MA, MI & OHOfficial notice →
  10. 2025-08-06
  11. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,…

    Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027

    FDA · DrugLupin Pharmaceuticals Inc.Nationwide in the USOfficial notice →
All 38 Lupin Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2026-07-08
  2. US
  3. US
    Drugs & medicalClass II

    Boehringer Ingelheim Pharmaceuticals, Inc. recalls Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets…

    CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

    FDA · DrugBoehringer Ingelheim Pharmaceuticals, Inc.OHOfficial notice →
  4. US
  5. US
    Drugs & medicalClass III

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc.,…

    Failed Impurities/Degradation Specifications

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCU.S. NationwideOfficial notice →
  6. US
  7. US
    Drugs & medicalClass II

    CareFusion 213, LLC recalls BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)), packaged as a) 100 x 10.5 mL…

    Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

    FDA · DrugCareFusion 213, LLCDistributed Nationwide in the USAOfficial notice →
See all drugs & medical recalls →